At the start of the year James Chisholm’s stake in Atrum Coal (ASX:ATU) was just under $4m. But he’s retired from the board and sold his shares to Regal Funds Management, which now holds 13.5 per cent of the company.

With Atrum’s rise from 9c to 30c, the sale netted him $12.8m. He walked out and sold his stake with the board’s blessing and no personal regrets. “After investing many years in Atrum, I feel now is the right time for me to depart and focus on my other business opportunities,” he said.

Another director who chose to sell more than $1m with departure imminent was Frontier Resources (ASX:FNT) director Yun Wei Dong – $3.6m to be exact. He was a representative of Forise Investments. The investor held 68 per cent and now holds just 5 per cent.

Five other directors sold over $100,000. Two of these were CoAssets (ASX:CA8) chairman Getty Goh Te-Win, who sold $300,000, and director Seh Huan Kiat, who cashed out $150,000. But both still own 36 per cent of the company between them.

Northern Minerals’ (ASX:NTU) George Bauk sold $139,860, and Colin McCavana sold $111,350. Both blamed a tax liability and Bauk said he would buy more shares in the upcoming capital raise.

Troy Resources director (ASX:TRY) John Sones sold $172,794 at the start of the week, then sold another $125,077 later in the week for a total of nearly $298,000. Gulf Manganese (ASX:GMC) director Hamish Bohannan sold $199,634.

Buyers

The biggest buyer (declaring) this week was Eagle Mountain Mining (ASX:EM2) director Charles Bass who bought nearly $1.1m.

Other mining directors who bought were Ironbark Zinc’s (ASX:IBG) Danny Segman who bought $113,136, Pelican Resources’ (ASX:PEL) Antinio Alessio Torresan who bought $182,359 through exercising options and Empire Energy (ASX: EEG) Paul Espie who bought $109,951.

Mobilicom (ASX:MOB) director Jonathan Brett bought $100,000 in a recent placement. He bought only two days after it announced the first sale of its SkyHopper – to Samsung.

Medicine is hot (including pot)

The next biggest traders were Sean Hall and Michael Hall from pot stock Medlab Clinical (ASX:MDC), who bought $651,000 and $255,000 respectively through exercising options.

This came only a week after the company received human ethics approval for the upcoming trial of its cannabis-based medicine.

Sean Hall said, “Early data received is very pleasing and this coupled with the learnings from the current Australian SAS usage, NanaBis is a strong contender for pain management and in my mind a viable pain management medication.” He’s certainly put his money where his mouth is.

Another health director who bought was Paradigm Biopharmaceuticals (ASX:PAR) director Christopher Fullerton.

He bought $169,920 in a rights issue and on-market trade. The rights issue purchase occurred two months ago and the latter last week — bringing the former to the company’s attention and the ASX’s when it was filed.

The ASX sent a ‘please explain’ letter to Paradigm, which reminded its directors of the company’s trading policy.

This aside, it has been a few positive months for the company. In early June it announced a trial showed its drug was effective at fighting Ross River virus.

Code Company Director Change Date Volume $ What Total holdings
EEG Empire Energy Paul Espie Buy 28 June 500,000 $109,951 On market 1,350,000
FNT Frontier Resources Yun Wei Dong Sell 27 June 309,294,903 $3,600,000 On market 24,455,097
GMC Gulf Maganese Corporation Hamish Bohannan Sell 26 June 31,938,926 $199,634 On market 72,618,090
WND Windlab Roger Price Buy 28 June 315,389 $157,695 Exercise of options 532765
MDC Medlab Clinical Sean Hall Buy 1 July 2,170,000 $651,000 Exercise of options 58,425,555
MDC Medlab Clinical Michael Hall Buy 1 July 850,000 $255,000 Exercise of options 12,334,445
TRY Troy Resources John Jones Sell 27-28 June 3,200,000 $297,871 On market 5,396,990
MOB Mobilicom Jonathan Brett Buy 13 May & 27 June 1,000,000 $100,000 Placement 1,500,000
PEL Pelican Resources Antonio Alessio Torresan Buy 2 July 18,235,896 $182,359 Exercise of options 77429877
PAR Paradigm Biopharmaceuticals Christopher Fullerton Buy 27 June 114,500 $169,920 On market 970,000
ATU Atrum Coal James Chisolm Sell 27 June 42,701,384 $12,810,415 On market 0
CA8 CoAssets Getty Goh Te-Win Sell 1 July 3,000,000 $300,000 Off market 43,128,810
CA8 CoAssets Seh Huan Kiat Sell 1 July 1,500,000 $150,000 Off market 34,633,030
NTI Northern Minerals George Bauk Sell 3 July 1,890,000 $139,860 On market 4,931,650
EM2 Eagle Mountain Mining Charles Bass Buy 17 June 7,330,000 $1,099,500 Rights Issue 43,980,001
IBG Ironbark Zinc Danny Segman Buy 4 July 7,000,000 $113,136 On market 104,750,000
NTI Northern Minerals Colin McCavana Sell 5 July 1,500,000 $111,350 On market 3,700,000